Literature DB >> 17991932

Health-related quality of life and symptom management research sponsored by the National Cancer Institute.

Lori M Minasian1, Ann M O'Mara, Bryce B Reeve, Andrea M Denicoff, Joseph Kelaghan, Julia H Rowland, Edward L Trimble.   

Abstract

For almost 30 years, the National Cancer Institute (NCI) has sponsored health-related quality-of-life (HRQOL) measures in cancer research as a means of including the patient's experience. The scope of NCI's research in symptom management and HRQOL is described with attention to its evolution over time and the next steps, through the Clinical Trials Working Group Recommendations.

Entities:  

Mesh：

Year:  2007        PMID： 17991932     DOI： 10.1200/JCO.2007.12.6672

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


  14 in total

1.  The satisfaction of Latina breast cancer survivors with their healthcare and health-related quality of life.

Authors:  Kimberly A Wildes; Alexander R Miller; Sandra San Miguel de Majors; Pamela M Otto; Amelie G Ramirez
Journal:  J Womens Health (Larchmt)       Date:  2011-07       Impact factor: 2.681

2.  The importance of symptom surveillance during follow-up care of leukemia, bladder, and colorectal cancer survivors.

Authors:  Erin E Kent; Sandra A Mitchell; Ingrid Oakley-Girvan; Neeraj K Arora
Journal:  Support Care Cancer       Date:  2013-09-10       Impact factor: 3.603

Review 3.  Key design and analysis principles for quality of life and patient-reported outcomes in clinical trials.

Authors:  Joseph M Unger; Riha Vaidya; John L Gore
Journal:  Urol Oncol       Date:  2018-03-21       Impact factor: 3.498

4.  Association of health-related quality of life with gender in patients with B-cell chronic lymphocytic leukemia.

Authors:  Chris L Pashos; Christopher R Flowers; Neil E Kay; Mark Weiss; Nicole Lamanna; Charles Farber; Susan Lerner; Jeff Sharman; David Grinblatt; Ian W Flinn; Mark Kozloff; Arlene S Swern; Thomas K Street; Kristen A Sullivan; Gale Harding; Zeba M Khan
Journal:  Support Care Cancer       Date:  2013-06-08       Impact factor: 3.603

5.  Reference values of the Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being: a report from the American Cancer Society's studies of cancer survivors.

Authors:  Alexis R Munoz; John M Salsman; Kevin D Stein; David Cella
Journal:  Cancer       Date:  2015-02-24       Impact factor: 6.860

6.  Validation of the Arabic version of the EORTC quality of life questionnaire among cancer patients in Lebanon.

Authors:  Huda Abu-Saad Huijer; Knar Sagherian; Hani Tamim
Journal:  Qual Life Res       Date:  2012-09-08       Impact factor: 4.147

7.  The religiosity/spirituality of Latina breast cancer survivors and influence on health-related quality of life.

Authors:  Kimberly A Wildes; Alexander R Miller; Sandra San Miguel de Majors; Amelie G Ramirez
Journal:  Psychooncology       Date:  2009-08       Impact factor: 3.894

8.  Feasibility of long-term patient self-reporting of toxicities from home via the Internet during routine chemotherapy.

Authors:  Timothy J Judson; Antonia V Bennett; Lauren J Rogak; Laura Sit; Allison Barz; Mark G Kris; Clifford A Hudis; Howard I Scher; Paul Sabattini; Deborah Schrag; Ethan Basch
Journal:  J Clin Oncol       Date:  2013-06-03       Impact factor: 44.544

9.  Managing symptoms among patients with breast cancer during chemotherapy: results of a two-arm behavioral trial.

Authors:  Charles W Given; Alla Sikorskii; Deimante Tamkus; Barbara Given; Mei You; Ruth McCorkle; Victoria Champion; David Decker
Journal:  J Clin Oncol       Date:  2008-11-24       Impact factor: 44.544

10.  Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial.

Authors:  Dan Stark; Matthew Nankivell; Eric Pujade-Lauraine; Gunnar Kristensen; Lorraine Elit; Martin Stockler; Felix Hilpert; Andrés Cervantes; Julia Brown; Anne Lanceley; Galina Velikova; Eduardo Sabate; Jacobus Pfisterer; Mark S Carey; Philip Beale; Wendi Qian; Ann Marie Swart; Amit Oza; Tim Perren
Journal:  Lancet Oncol       Date:  2013-01-18       Impact factor: 41.316
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.